v2.4.0.8
Restatement of Condensed Consolidated Financial Statements (Details) (USD $)
3 Months Ended 6 Months Ended 83 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Dec. 31, 2012
Condensed Consolidated Balance Sheets            
Deficit accumulated during the development stage $ 49,741,101   $ 49,741,101   $ 49,741,101 $ 46,233,234
Condensed Consolidated Statements of Operations            
Net loss attributable to common shareholders (1,950,871) (612,965) (3,507,867) (1,511,876) (49,741,101)  
Net loss per share – basic and diluted $ (0.15) $ (0.05) $ (0.28) $ (0.13)    
Condensed Consolidated Statement of Changes in Stockholders’ Deficit            
Deficit accumulated during the development stage 49,741,101   49,741,101   49,741,101 46,233,234
As Previously Reported
           
Condensed Consolidated Balance Sheets            
Additional paid-in capital 47,564,257   47,564,257   47,564,257  
Deficit accumulated during the development stage (49,771,659)   (49,771,659)   (49,771,659)  
Condensed Consolidated Statements of Operations            
Deemed dividend – beneficial conversion feature     (180,502)   (180,502)  
Net loss attributable to common shareholders     (3,398,425)   (49,771,659)  
Net loss per share – basic and diluted     $ (0.28)      
Condensed Consolidated Statement of Changes in Stockholders’ Deficit            
Deemed dividend related to beneficial conversion feature of Series A non-voting preferred stock Impact on Additional Paid in Capital     180,502      
Additional paid-in capital 47,564,257   47,564,257   47,564,257  
Deemed dividend related to beneficial conversion feature of Series A non-voting preferred stock Impact on Deficit Accumulated During the Development Stage     (180,502)      
Deficit accumulated during the development stage (49,771,659)   (49,771,659)   (49,771,659)  
Condensed Consolidated Statement of Cash Flows            
Deemed dividend – beneficial conversion feature     180,502   180,502  
As Restated
           
Condensed Consolidated Balance Sheets            
Additional paid-in capital 47,693,699   47,693,699   47,693,699  
Deficit accumulated during the development stage (49,901,101)   (49,901,101)   (49,901,101)  
Condensed Consolidated Statements of Operations            
Deemed dividend – beneficial conversion feature     (309,944)   (309,944)  
Net loss attributable to common shareholders     (3,527,867)   (49,901,101)  
Net loss per share – basic and diluted     $ (0.29)      
Condensed Consolidated Statement of Changes in Stockholders’ Deficit            
Deemed dividend related to beneficial conversion feature of Series A non-voting preferred stock Impact on Additional Paid in Capital     309,944      
Additional paid-in capital 47,693,699   47,693,699   47,693,699  
Deemed dividend related to beneficial conversion feature of Series A non-voting preferred stock Impact on Deficit Accumulated During the Development Stage     (309,944)      
Deficit accumulated during the development stage (49,901,101)   (49,901,101)   (49,901,101)  
Condensed Consolidated Statement of Cash Flows            
Deemed dividend – beneficial conversion feature     $ 309,944   $ 309,944